EMA
safety_alert
· 2020-03-27
Restrictions in use of cyproterone due to meningioma risk
Summary
The EMA restricted the use of cyproterone due to an increased risk of meningioma, outlining limitations on indications and duration of use and recommending alte…
Upgrade for the full analysis, importance score, and drug timeline.